Adam S. Mostafa X4 Pharmaceuticals, Inc (XFOR) insider trading activity

Adam S. Mostafa is Chief Financial Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 0 shares of XFOR, which is worth approximately $0. The most recent transaction as insider was on Oct 07, 2024, when has been sold 230,645 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $126,854. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Adam S. Mostafa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 07 2024	SELL Open market or private sale	$126,854 $0.55 p/Share	230,645 Reduced 100.0%	0 Common Stock
Oct 04 2024	BUY Grant, award, or other acquisition	-	230,645 Added 50.0%	230,645 Common Stock
Mar 11 2024	SELL Open market or private sale	$46,200 $0.88 p/Share	52,500 Reduced 100.0%	0 Common Stock
Feb 12 2024	SELL Open market or private sale	$27,998 $1.01 p/Share	27,721 Reduced 34.56%	52,500 Common Stock
Nov 01 2023	SELL Open market or private sale	$168,370 $0.73 p/Share	230,645 Reduced 74.19%	80,221 Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	-	230,645 Added 42.59%	310,866 Common Stock
Jun 30 2023	SELL Open market or private sale	$4,991 $1.89 p/Share	2,641 Reduced 3.19%	80,221 Common Stock
Jun 23 2023	SELL Open market or private sale	$10,454 $1.93 p/Share	5,417 Reduced 6.14%	82,862 Common Stock
Jun 15 2023	SELL Open market or private sale	$12,025 $2.22 p/Share	5,417 Reduced 5.78%	88,279 Common Stock
Mar 10 2023	SELL Open market or private sale	$44,100 $0.84 p/Share	52,500 Reduced 35.91%	93,696 Common Stock
Feb 13 2023	SELL Open market or private sale	$25,780 $0.93 p/Share	27,721 Reduced 15.94%	146,196 Common Stock
Aug 17 2022	SELL Open market or private sale	-	10,834 Reduced 5.86%	173,917 Common Stock
Jun 30 2022	SELL Open market or private sale	-	2,641 Reduced 1.41%	184,751 Common Stock
Jun 24 2022	SELL Open market or private sale	-	5,416 Reduced 2.81%	187,392 Common Stock
Jun 16 2022	SELL Open market or private sale	-	5,416 Reduced 2.73%	192,808 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	105,000 Added 34.63%	198,224 Common Stock
Feb 11 2022	SELL Open market or private sale	-	27,721 Reduced 22.92%	93,224 Common Stock
Aug 17 2021	SELL Open market or private sale	$55,243 $5.1 p/Share	10,832 Reduced 8.22%	120,945 Common Stock
Jun 30 2021	SELL Open market or private sale	$17,536 $6.64 p/Share	2,641 Reduced 1.96%	131,777 Common Stock
Jun 24 2021	SELL Open market or private sale	$37,973 $7.01 p/Share	5,417 Reduced 3.87%	134,418 Common Stock
Jun 23 2021	BUY Grant, award, or other acquisition	-	16,250 Added 10.41%	139,835 Common Stock
Jun 15 2021	SELL Open market or private sale	$42,469 $7.84 p/Share	5,417 Reduced 4.2%	123,585 Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	16,250 Added 11.19%	129,002 Common Stock
Mar 24 2021	BUY Grant, award, or other acquisition	-	83,163 Added 42.45%	112,752 Common Stock

ASM

Adam S. Mostafa

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Value

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to X4 Pharmaceuticals, Inc

Track Activities on XFOR

Account